Cardiovascular death and first heart failure hospitalization was reduced among HFrEF patients compared to HFmrEF and HFpEF ...
Grade 3-5 adverse events were comparable between both treatment groups. Evidence Rating Level: 1 (Excellent) Study Rundown: ...
In this cross-sectional study, researchers found that Native Hawaiian and Pacific Islander (NHPI) adults aged 35 years or ...
1. This follow-up analysis of the phase 3 REPRIEVE trial demonstrated that region of residence, prediabetes, high BMI, and metabolic ...
In this randomized controlled trial, among adolescent girls and young women, it was found that twice-yearly lenacapavir ...
FluMist is an efficacious and safely tolerated intranasal influenza vaccine. FluMist has gained approval from the FDA for ...
In a randomized triple-blinded controlled trial, probiotic and vitamin D supplementation did not significantly change ...
Zodasiran, an RNA interference (RNAi) therapy targeting angiopoietin-like 3 (ANGPTL3), resulted in a dose-dependent reduction ...